background
airway
lung
cancer
patient
often
colon
fungi
colon
fungi
particular
condit
produc
cancerogen
mycotoxin
given
recent
interest
infect
origin
lung
cancer
preliminari
studi
aim
give
small
contribut
field
research
analys
fungal
microbiom
exhal
breath
condens
lung
cancer
patient
puglia
region
itali
method
enrol
lung
cancer
patient
healthi
subject
underw
exhal
breath
condens
bronchial
brush
collect
fungal
incid
natur
sampl
collect
analys
use
select
media
aspergillu
speci
result
first
time
abl
analys
fungal
microbioma
exhal
breath
condens
lung
cancer
patient
show
presenc
aspergillu
niger
ochraceu
penicillium
ssp
none
healthi
subject
conclus
result
confirm
high
percentag
fungal
colon
airway
lung
cancer
patient
puglia
suggest
need
conduct
analys
field
order
evalu
exact
pathogenet
role
fungi
lung
cancer
well
propos
effici
empir
therapi
lung
airway
perpetu
expos
inhal
particul
materi
includ
pollen
virus
bacteri
fungal
spore
mani
particl
innocu
spore
potenti
germin
caus
invas
lung
diseas
recent
theori
suggest
infect
could
also
trigger
lung
cancerogenesi
hypothesi
formul
mainli
virus
although
exclud
also
bacteria
fungi
could
involv
possibl
infect
could
caus
lung
cancer
sure
lung
subject
cancer
particularli
suscept
infect
significantli
compromis
patient
prognosi
spectrum
pulmonari
infect
depend
underli
immunolog
deficit
deficit
wherea
fungal
infect
common
neutropenia
persist
lung
cancer
also
character
airway
inflamm
usual
follow
cigarett
smoke
like
play
role
cancer
transform
inflammatori
statu
also
compromis
host
lung
promot
tissu
invas
system
dissemin
infect
main
fungu
could
play
role
lung
cancer
transform
colon
airway
aspergillu
mold
form
conidia
owe
small
size
bypass
mucociliari
clearanc
mechan
inhal
termin
airway
phagocytos
alveolar
macrophag
toxigen
aspergillu
speci
common
mediterranean
environ
colon
differ
crop
includ
maiz
grape
dri
fruit
known
abl
produc
mycotoxin
aflatoxin
ochratoxin
fumonisin
host
plant
stress
extrem
temperatur
moistur
condit
poor
soil
fertil
insect
damag
despit
potenti
clinic
therapeut
consequ
hypothes
lung
cancerogenesi
trigger
fungal
infect
particularli
aspergillu
notwithstand
preval
rate
mold
colon
lung
cancer
patient
significantli
increas
last
decad
comprehens
studi
avail
field
studi
present
literatur
describ
airway
fungal
colon
lung
cancer
patient
oneoff
report
simpli
express
consequ
immunodepress
statu
characterist
tumour
howev
sever
studi
avail
support
viral
origin
lung
cancer
among
studi
one
emerg
group
recent
analys
viral
colon
exhal
breath
condens
ebc
nonsmal
cell
lung
cancer
nsclc
patient
involv
sampl
airway
complet
noninvas
appar
suitabl
microbiolog
studi
unpublish
data
support
potenti
sampl
contain
volatil
solubl
omic
marker
alreadi
demonstr
use
noninvas
diagnosi
sever
lung
diseas
particularli
lung
cancer
still
result
mani
fatal
mainli
alway
diagnos
advanc
stage
noninvas
screen
tool
provid
key
earli
detect
improv
person
chanc
surviv
studi
want
give
preliminari
contribut
field
research
give
view
incid
natur
fungal
colonis
lung
cancer
patient
puglia
correl
eventu
posit
anthropometr
clinic
oncolog
data
thu
first
time
knowledg
analys
fungal
microbiom
ebc
compar
result
pair
bronchial
brush
characterist
patient
consecut
patient
suspicion
lung
cancer
consent
studi
enrol
unit
thorac
surgeri
casa
di
cura
la
madonnina
bari
depart
respiratori
diseas
foggia
univers
tabl
written
inform
consent
obtain
subject
upon
approv
studi
ethic
committe
univers
foggia
patient
enrol
studi
patholog
diagnosi
also
underw
standard
stage
procedur
consist
physic
examin
serum
chemistri
analysi
brain
chest
abdomen
ct
scan
radionuclid
bone
scan
case
definit
diagnosi
malign
deriv
posit
cytohistolog
sampl
obtain
broncoscop
follow
histolog
analysi
carri
specimen
subject
turn
neg
consid
control
remain
subject
suspicion
lung
cancer
confirm
squamou
cell
carcinoma
diagnos
subject
wherea
subject
found
affect
adenocarcinoma
overal
nsclc
patient
classifi
stage
stage
ii
stage
iii
stage
iv
subject
underw
ebc
bronchial
brush
collect
latter
carri
bronchoscopi
subject
underw
fungal
investig
sampl
type
frequenc
colonis
analyz
inform
smoke
habit
acquir
time
diagnosi
twentyf
nsclc
patient
current
exsmok
packyear
exsmok
quit
smoke
year
previous
wherea
nonsmok
detail
histori
relat
famili
histori
lung
cancer
cancer
collect
pretest
proform
bronchial
brush
specimen
collect
icecold
phosphatebuff
salin
solut
fiberopt
bronchoscopi
sampl
transfer
freshli
prepar
dichloran
rosebeng
chloramphenicol
agar
drbc
oxoid
medium
plate
incub
day
examin
daili
ebc
collect
process
ml
ebc
one
set
patient
time
diagnosi
ebc
collect
use
condens
ecoscreen
jaeger
wurzburg
germani
condens
transfer
freshli
prepar
dichloran
rosebeng
chloramphenicol
agar
drbc
oxoid
medium
plate
incub
day
examin
daili
aspergillu
coloni
subcultur
subsequ
identif
speci
level
speci
name
determin
follow
taxonom
key
klich
cultur
incub
day
cya
czapek
yeast
extract
agar
cz
czapekdox
agar
mea
malt
extract
agar
enabl
morpholog
featur
exploit
diagnost
charact
penicillium
coloni
identifi
genu
level
order
assess
associ
categor
variabl
sex
smoke
habit
fungi
posit
brush
ebc
posit
lung
cancer
histolog
subtyp
tnm
stage
mold
posit
chi
squar
test
fisher
exact
test
necessari
calcul
tstudent
use
independ
sampl
order
assess
differ
continu
variabl
age
number
packyear
smoke
lung
cancer
patient
control
p
valu
consid
statist
signific
lung
cancer
case
healthi
subject
enrol
present
studi
number
respect
demograph
clinic
data
studi
subject
summar
tabl
abl
detect
fungal
colon
aspergillu
niger
aspergillu
ochraceu
penicillium
ssp
ebc
nsclc
patient
control
turn
fungi
colon
ebc
aspergillu
niger
aspergillu
ochraceu
penicillum
spp
fungi
posit
ebc
alway
confirm
pair
bronchial
brush
ebc
found
similar
sensibl
compar
bronchial
brush
fungi
detect
analyz
lung
cancer
patient
differ
found
accord
sex
age
histotyp
stage
smoke
habit
pack
year
time
sinc
quit
smoke
subject
fungal
colon
p
preliminari
studi
aim
analys
incid
natur
fungal
colon
lung
cancer
patient
region
puglia
itali
first
time
knowledg
test
fungal
microbioma
exhal
breath
condens
pair
bronchial
brush
patient
diagnos
lung
cancer
healthi
subject
lung
cancer
patient
detect
presenc
mold
aspergillu
niger
ochraceu
penicillium
ssp
healthi
subject
fungal
posit
airway
nt
correl
oncolog
data
suggest
fungal
colon
could
contribut
trigger
viru
infect
hpv
cmv
etc
pathophysiolog
process
associ
lung
cancer
howev
evid
involv
specif
fungal
speci
asthma
chronic
obstruct
pulmonari
diseas
copd
cystic
fibrosi
cf
littl
known
airway
fungal
microbiota
pathogenesi
lung
cancer
given
nascent
airway
microbiom
research
lung
cancer
recent
effort
advanc
area
articl
analys
fungal
microbiota
ebc
bronchial
aspir
lung
cancer
patient
region
puglia
itali
studi
investig
fungal
colon
airway
lung
cancer
patient
use
bronchial
aspir
bronchoalveolar
lavag
sputum
lung
tissu
studi
describ
fungal
posit
oneoff
report
result
immunodepress
bear
mind
identifi
risk
factor
smoke
habit
could
socioeconom
consequ
lung
cancer
offer
use
tool
prevent
program
still
state
bankruptci
design
preliminari
studi
aim
analys
possibl
fungal
involv
lung
cancerogenesi
consider
use
use
noninvas
method
analys
airway
patient
feel
brunt
sever
diagnost
test
often
surgeri
test
fungal
microbiom
first
time
ebc
group
previous
demonstr
possibl
analys
viral
colon
sampl
patient
affect
lung
cancer
support
recent
theori
possibl
infect
aetiolog
lung
tumour
studi
sought
direct
effort
identif
new
cancerogen
microrgan
ebc
toward
screen
program
could
direct
test
fungal
microbiom
found
posit
aspergillu
niger
ochraceu
sampl
lung
cancer
patient
speci
fungi
may
releas
cancerogen
mycotoxin
ocratoxin
e
fumonisin
find
led
us
suggest
also
microorgan
toxic
secondari
metabolit
may
play
role
lung
cancer
develop
although
studi
need
support
hypothesi
furthermor
observ
fungal
posit
sampl
alway
observ
pair
bronchial
brush
overlap
mold
ebc
bronchial
brush
prove
ebc
contain
ident
inform
airway
colonis
previous
demonstr
hpv
cmv
ebv
unpublish
data
somat
dna
alter
specif
lung
cancer
also
support
high
sensibl
specif
sampl
confirm
potenti
use
oncolog
clinic
practic
unabl
find
correl
fungi
posit
sex
age
histotyp
stage
smoke
habit
subject
studi
would
help
us
definit
pathogenet
role
fungi
identifi
lung
cancer
patient
howev
number
patient
enrol
studi
low
justifi
result
intend
verifi
larger
popul
anoth
recogn
limit
studi
test
presenc
fungi
pair
plasma
someth
might
help
us
better
interpret
origin
fungi
airway
patient
lung
cancer
also
signific
import
analys
address
also
analyz
fungal
genotyp
isol
order
ass
abil
produc
toxin
evalu
effect
presenc
human
fluid
lung
tumor
tissu
mycotoxin
potenti
produc
aspergillu
speci
isol
preliminari
studi
follow
genom
epigenom
character
mycotoxin
analysi
hope
help
us
defin
associ
mold
lung
cancerogenesi
pathogenet
mechan
involv
plan
better
studi
whether
fungi
colon
caus
consequ
lung
cancer
investig
immunolog
statu
fungiposit
patient
analysi
densiti
infiltr
inflammatori
cell
surgic
tissu
sampl
dosag
plasmat
immunoglobin
concentr
conclus
state
demonstr
exhal
breath
condens
suitabl
sampl
even
fungal
colon
airway
furthemor
found
lung
cancer
patient
region
puglia
itali
show
apergillu
niger
aspergillu
ochraceu
penicillium
spp
airway
open
futur
perspect
field
studi
could
nt
verifi
whether
fungal
colon
caus
consequ
lung
cancer
offer
broader
view
infect
statu
airway
lung
cancer
patient
consider
potenti
result
support
futur
studi
emerg
field
could
open
possibl
microbiota
manipul
novel
therapeut
strategi
screen
treatment
manag
lung
cancer
abbrevi
ebc
exhal
breath
condens
nt
financi
disclosur
author
author
contribut
gec
design
present
studi
draft
manuscript
dl
enrol
patient
gpp
carri
bronchial
brush
analys
gl
enrol
patient
ec
enrol
patient
particip
fungal
cultur
analysi
al
particip
fungal
analysi
design
present
studi
mpfb
review
manuscript
author
read
approv
final
manuscript
author
detail
institut
respiratori
diseas
depart
medic
occup
scienc
univers
foggia
foggia
itali
univers
bari
bari
itali
institut
scienc
food
product
research
nation
council
bari
itali
